Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,680 signal articles · 44 in last 24h · 156,126 total before filter · latest 1h ago
44last 24h
853last 7d
150● bullish (7d)
86● bearish (7d)
214publishers
AllMacro190Earnings112M&A124Regulatory20Product19Analyst21
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
3 Reasons to Avoid FRME and 1 Stock to Buy Instead
StockStory33d agobullish
3 Reasons to Avoid FRME and 1 Stock to Buy Instead

Since February 2026, First Merchants has been in a holding pattern, posting a small return of 2% while floating around $41.94. The stock also fell short of the S&P 500’s 10.5% gain during that period.

Merck (MRK) Surges on a Melanoma Win. Can Intismeran Extend Keytruda’s Growth Runway?
Insider Monkey33d agobullish
Merck (MRK) Surges on a Melanoma Win. Can Intismeran Extend Keytruda’s Growth Runway?

Merck & Co., Inc. (NYSE:MRK) jumped 12.6% to a record $152.20 on August 19 after a pivotal melanoma trial validated intismeran autogene, the individualized mRNA cancer therapy developed with Moderna. In the 1,137-patient Phase 3 INTerpath-001 study, intismeran plus Keytruda produced statistically significant and clinically meaningful improvements in recurrence-free survival and distant-metastasis-free survival compared with […]

3 Reasons NWBI is Risky and 1 Stock to Buy Instead
StockStory33d agobullish
3 Reasons NWBI is Risky and 1 Stock to Buy Instead

Northwest Bancshares’s 19% return over the past six months has outpaced the S&P 500 by 8.5%, and its stock price has climbed to $15.38 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Here's Why AXT (AXTI) Is a Great 'Buy the Bottom' Stock Now
Zacks33d agobullish
Here's Why AXT (AXTI) Is a Great 'Buy the Bottom' Stock Now

AXT (AXTI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

3 Reasons to Avoid AMKR and 1 Stock to Buy Instead
StockStory33d agobullish
3 Reasons to Avoid AMKR and 1 Stock to Buy Instead

Over the past six months, Amkor’s stock price fell to $47.82. Shareholders have lost 6.1% of their capital, which is disappointing considering the S&P 500 has climbed by 10.5%. This may have investors wondering how to approach the situation.